Cargando…

Risk behaviours among HIV positive injecting drug users in Myanmar: a case control study

BACKGROUND: The severity of HIV/AIDS pandemic linked to injecting drug use is one of the most worrying medical and social problems throughout the world in recent years. Myanmar has one of the highest prevalence rates of HIV among the IDUs in the region. AIM: The objective of the study was to determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Swe, Lin A, Nyo, Kay K, Rashid, AK
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890662/
https://www.ncbi.nlm.nih.gov/pubmed/20515507
http://dx.doi.org/10.1186/1477-7517-7-12
_version_ 1782182829779582976
author Swe, Lin A
Nyo, Kay K
Rashid, AK
author_facet Swe, Lin A
Nyo, Kay K
Rashid, AK
author_sort Swe, Lin A
collection PubMed
description BACKGROUND: The severity of HIV/AIDS pandemic linked to injecting drug use is one of the most worrying medical and social problems throughout the world in recent years. Myanmar has one of the highest prevalence rates of HIV among the IDUs in the region. AIM: The objective of the study was to determine the risk behaviours among HIV positive injecting drug users in Myanmar. METHODS: A non matched case control study was conducted among 217 respondents registered with a non governmental organization's harm reduction center. 78 HIV positive IDUs were used as cases and 139 non HIV positive IDUs as controls. The study was conducted between April-May 2009. Data was analysed using SPSS version 15 and the study was ethically conducted. RESULTS: Factors like age, marital status, age first used drugs, drug use expenditure, reason for drug use, age first used injection were found to be significant. Other risk factors found significantly associated with HIV among IDU were education (OR 2.3), location of respondent (OR 2.4) type of syringe first used (OR 5.1), sharing syringe at the first injection (OR 4.5) and failure of drug detoxification programme (OR 4.9). More HIV positive IDUs were returning used syringes in the centre (OR 3.3). CONCLUSIONS: Prudent measures such as access to sterile syringes and continuous health education programmes among IDUs and their sexual partners are required to reduce high risk behaviours of IDUs in Myanmar.
format Text
id pubmed-2890662
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28906622010-06-24 Risk behaviours among HIV positive injecting drug users in Myanmar: a case control study Swe, Lin A Nyo, Kay K Rashid, AK Harm Reduct J Research BACKGROUND: The severity of HIV/AIDS pandemic linked to injecting drug use is one of the most worrying medical and social problems throughout the world in recent years. Myanmar has one of the highest prevalence rates of HIV among the IDUs in the region. AIM: The objective of the study was to determine the risk behaviours among HIV positive injecting drug users in Myanmar. METHODS: A non matched case control study was conducted among 217 respondents registered with a non governmental organization's harm reduction center. 78 HIV positive IDUs were used as cases and 139 non HIV positive IDUs as controls. The study was conducted between April-May 2009. Data was analysed using SPSS version 15 and the study was ethically conducted. RESULTS: Factors like age, marital status, age first used drugs, drug use expenditure, reason for drug use, age first used injection were found to be significant. Other risk factors found significantly associated with HIV among IDU were education (OR 2.3), location of respondent (OR 2.4) type of syringe first used (OR 5.1), sharing syringe at the first injection (OR 4.5) and failure of drug detoxification programme (OR 4.9). More HIV positive IDUs were returning used syringes in the centre (OR 3.3). CONCLUSIONS: Prudent measures such as access to sterile syringes and continuous health education programmes among IDUs and their sexual partners are required to reduce high risk behaviours of IDUs in Myanmar. BioMed Central 2010-06-02 /pmc/articles/PMC2890662/ /pubmed/20515507 http://dx.doi.org/10.1186/1477-7517-7-12 Text en Copyright ©2010 Swe et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Swe, Lin A
Nyo, Kay K
Rashid, AK
Risk behaviours among HIV positive injecting drug users in Myanmar: a case control study
title Risk behaviours among HIV positive injecting drug users in Myanmar: a case control study
title_full Risk behaviours among HIV positive injecting drug users in Myanmar: a case control study
title_fullStr Risk behaviours among HIV positive injecting drug users in Myanmar: a case control study
title_full_unstemmed Risk behaviours among HIV positive injecting drug users in Myanmar: a case control study
title_short Risk behaviours among HIV positive injecting drug users in Myanmar: a case control study
title_sort risk behaviours among hiv positive injecting drug users in myanmar: a case control study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890662/
https://www.ncbi.nlm.nih.gov/pubmed/20515507
http://dx.doi.org/10.1186/1477-7517-7-12
work_keys_str_mv AT swelina riskbehavioursamonghivpositiveinjectingdrugusersinmyanmaracasecontrolstudy
AT nyokayk riskbehavioursamonghivpositiveinjectingdrugusersinmyanmaracasecontrolstudy
AT rashidak riskbehavioursamonghivpositiveinjectingdrugusersinmyanmaracasecontrolstudy